AI is improving idiopathic pulmonary fibrosis care
The integration of AI into the management of IPF represents a significant advancement in the field.
Artificial Intelligence
Five lessons from biopharma companies’ data transformation journeys
AI in drug discovery: from hypothetical to reality
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?
